Pharmaceutical formulations of a pan-RAF kinase inhibitor and processes for their preparation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10426782
APP PUB NO 20170173033A1
SERIAL NO

15128714

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a pharmaceutical composition comprising Compound 1 or a pharmaceutically acceptable salt thereof for the treatment of cancer and a process for its preparation. The invention also relates to administering the pharmaceutical composition to a patient according to an intermittent dosing regimen.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DAY ONE BIOPHARMACEUTICALS INC2000 SIERRA POINT PARKWAY SUITE 501 BRISBANE CA 94005

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bozon, Viviana West Newton, US 7 1
Brake, Rachael L Natick, US 9 8
Chow, Ching-Kuo J Littleton, US 1 1
Dinunzio, James C Bridgewater, US 9 54
Galvin, Katherine M Newton, US 26 107
Kannan, Karuppiah Newton, US 9 4
Kodono, Yuki Osaka, JP 2 1
Xu, Qunli Wellesley, US 12 22

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 1, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 1, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00